Affinage

SYAP1

Synapse-associated protein 1 · UniProt Q96A49

Length
352 aa
Mass
39.9 kDa
Annotated
2026-06-10
11 papers in source corpus 6 papers cited in narrative 6 extracted findings
Cross-family judge vs UniProt: tie faithfulness: 4/4 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

SYAP1, the mammalian homologue of Drosophila synapse-associated protein SAP47, is a broadly expressed adaptor that participates in growth-factor signaling and synaptic biology (PMID:12549212). It functions within a complex that promotes phosphorylation of Akt1 at Ser473, but this role is cell-type-specific: it operates in cultured adipocytes yet is dispensable for Akt Ser473/Thr308 phosphorylation in motoneurons (PMID:27344443). SYAP1 physically interacts with Dlk2 to drive activation of Akt-Ser473, ERK1/2, and p38 signaling during osteoclast formation (PMID:37669921). Within neurons it localizes to synaptic neuropil, perinuclear Golgi-associated structures, and axons and growth cones of motoneurons (PMID:27344443), and its high expression in cerebellar Purkinje cells and cerebellar nuclei underlies a role in sensorimotor control, since SYAP1 knockout mice show selective deficits in locomotor activity and rotarod balance without cognitive or anxiety impairment (PMID:31118165). Beyond these signaling and synaptic roles, no unifying biochemical mechanism for SYAP1 has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 2001 Low

    Established the molecular identity of SYAP1, defining it as a human protein homologous to Drosophila SAP47 and showing it is broadly transcribed, which framed it as a candidate synapse-associated protein.

    Evidence cDNA cloning, Northern blot, and RT-PCR across human tissues

    PMID:12549212

    Open questions at the time
    • No functional assay performed
    • Subcellular localization and protein partners undefined
    • Isoform-specific functions not addressed
  2. 2006 Low

    Linked SYAP1 protein abundance to estrogen-receptor signaling, raising the question of whether SYAP1 is a regulated downstream effector of hormonal pathways.

    Evidence 2D gel electrophoresis proteomics in ERα-positive vs ERα-negative breast cancer cell lines

    PMID:16949628

    Open questions at the time
    • Correlative protein-level change only, no mechanism for SYAP1
    • No causal link between SYAP1 and ER-dependent phenotype
    • Not extended beyond cell lines
  3. 2016 Medium

    Tested whether SYAP1's Akt-Ser473-promoting role is universal and revealed it is cell-type-specific, while mapping its subcellular distribution in neurons.

    Evidence Syap1 knockout mouse, immunofluorescence/subcellular fractionation, and phospho-Akt Western blot in cultured motoneurons

    PMID:27344443

    Open questions at the time
    • Molecular basis of the cell-type specificity unresolved
    • Composition of the Akt-phosphorylating complex not defined
    • Function at Golgi/growth cone localization not established
  4. 2019 Medium

    Defined the in vivo physiological consequence of SYAP1 loss, attributing a discrete cerebellar sensorimotor function rather than a general neurological role.

    Evidence Syap1 knockout mouse behavioral battery and immunohistochemistry

    PMID:31118165

    Open questions at the time
    • Cellular mechanism connecting SYAP1 to Purkinje cell function unknown
    • No link drawn between behavioral phenotype and Akt signaling
    • Circuit-level basis of the deficit unaddressed
  5. 2023 Medium

    Identified a direct protein partner (Dlk2) and a defined signaling output, establishing SYAP1 as an interaction-dependent activator of Akt/ERK/p38 in osteoclast differentiation.

    Evidence Co-immunoprecipitation, in vitro and in vivo genetic knockout, and phosphorylation assays

    PMID:37669921

    Open questions at the time
    • Structural basis of the Syap1–Dlk2 interaction unknown
    • Whether this complex underlies SYAP1 signaling in other cell types untested
    • Direct kinase substrate relationship not resolved
  6. 2025 Low

    Implicated SYAP1 in regulating surface complement-regulatory protein CD59 on endothelial cells and as a target of SARS-CoV-2 proteins.

    Evidence Genome-wide CRISPR/Cas9 screen and complement cytotoxicity assay

    PMID:39945674

    Open questions at the time
    • Screen hit without SYAP1-specific mechanistic follow-up
    • Mechanism by which SYAP1 controls CD59 levels unknown
    • Direct interaction with viral proteins not demonstrated

Open questions

Synthesis pass · forward-looking unresolved questions
  • The unifying biochemical activity of SYAP1 — how a single adaptor reconciles cell-type-specific Akt regulation, Dlk2-dependent multi-kinase activation, cerebellar function, and CD59 control — remains undefined.
  • No catalytic or structural activity assigned to SYAP1
  • No comprehensive interactome
  • Connection between neuronal localization and signaling roles unestablished

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2
Localization
GO:0005794 Golgi apparatus 1 GO:0005886 plasma membrane 1
Pathway
R-HSA-162582 Signal Transduction 2
Partners

Evidence

Reading pass · 6 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2023 Syap1 interacts with Dlk2 and regulates Akt phosphorylation at Ser473 during osteoclast formation; Dlk2 deletion inhibited Syap1-mediated activation of AktSer473, ERK1/2, and p38 signaling cascades, and Dlk2-deficient mice showed a high-bone-mass phenotype. Co-immunoprecipitation (protein interaction), genetic knockout in vitro and in vivo, phosphorylation assays Cell death & disease Medium 37669921
2016 Syap1 functions as part of a complex that phosphorylates Akt1 at Ser473 in cultured adipocytes (previously established context). However, in cultured motoneurons, neither knockdown nor knockout of Syap1 reduced Ser473 or Thr308 phosphorylation of Akt, indicating a cell-type-specific role. Syap1 localizes to synaptic neuropil, perinuclear Golgi-associated structures in neuronal cell bodies, and in axons and growth cones of motoneurons. Syap1 knockout mouse generation, immunofluorescence/subcellular fractionation, Western blot for Akt phosphorylation in cultured motoneurons Histochemistry and cell biology Medium 27344443
2019 Syap1 knockout mice display specific deficits in spontaneous locomotor activity and rotarod balance/sensorimotor adaptation, associated with high Syap1 expression in cerebellar Purkinje cells and cerebellar nuclei, implicating Syap1 in cerebellar sensorimotor control. Cognitive and anxiety-related behaviors were unaffected. Syap1 knockout mouse, behavioral battery (SHIRPA, rotarod, open field, fear conditioning, novel object recognition), immunohistochemistry Biology open Medium 31118165
2025 SYAP1 was identified by CRISPR/Cas9-gRNA library screening as an intrinsic regulator of CD59 (a membrane complement regulatory protein) on endothelial cells; SARS-CoV-2 M, NSP16, and ORF9b proteins inhibit SYAP1 (among other regulators), leading to reduced CD59 levels and enhanced complement-mediated cytotoxicity. CRISPR/Cas9 genome-wide screen, functional complement cytotoxicity assay Emerging microbes & infections Low 39945674
2001 SYAP1 was cloned as a full-length human cDNA encoding a protein homologous to Drosophila SAP47 (synapse-associated protein of 47 kDa); two transcript isoforms were detected by Northern blot in human liver cells, and mRNA was broadly expressed in adult tissues. DD-PCR, cDNA library cloning, Northern blot, RT-PCR Shi yan sheng wu xue bao Low 12549212
2006 SYAP1 protein levels are differentially regulated by 17β-estradiol, 4-hydroxytamoxifen, and acolbifene in T47D breast cancer cells in an ERα-dependent manner (no effect in ERα-negative MDA-MB-231 cells), as identified by 2D gel electrophoresis proteomics. 2D gel electrophoresis, mass spectrometry protein identification, RT-PCR for mRNA in ERα-positive and -negative cell lines Steroids Low 16949628

Source papers

Stage 0 corpus · 11 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2021 Identification of Gender-Specific Molecular Differences in Glioblastoma (GBM) and Low-Grade Glioma (LGG) by the Analysis of Large Transcriptomic and Epigenomic Datasets. Frontiers in oncology 33 34621669
2006 Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells. Steroids 20 16949628
2024 Chromosome X-wide common variant association study in autism spectrum disorder. American journal of human genetics 18 39706197
2019 An essential role of the mouse synapse-associated protein Syap1 in circuits for spontaneous motor activity and rotarod balance. Biology open 9 31118165
2023 Dlk2 interacts with Syap1 to activate Akt signaling pathway during osteoclast formation. Cell death & disease 8 37669921
2018 Live cell imaging of X chromosome reactivation during somatic cell reprogramming. Biochemistry and biophysics reports 4 30094351
2004 Organization and annotation of the Xcat critical region: elimination of seven positional candidate genes. Genomics 4 15081118
2016 Initial characterization of a Syap1 knock-out mouse and distribution of Syap1 in mouse brain and cultured motoneurons. Histochemistry and cell biology 3 27344443
2001 [Cloning and characterization of syap1, a down regulated gene in human hepatocellular carcinoma]. Shi yan sheng wu xue bao 3 12549212
2025 SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins. Emerging microbes & infections 2 39945674
2024 Chromosome X-Wide Common Variant Association Study (XWAS) in Autism Spectrum Disorder. medRxiv : the preprint server for health sciences 2 39108515

Missed literature

Know a paper Affinage missed for SYAP1? Flag it for the maintainers and the community.

No submissions yet.